Skip to main content
Top
Published in: Infectious Diseases and Therapy 2/2020

Open Access 01-06-2020 | Original Research

Reducing Blood Culture Contamination Rates: Experiences of Four Hospital Systems

Authors: Diane C. Halstead, Robert L. Sautter, James W. Snyder, Arthur E. Crist, Irving Nachamkin

Published in: Infectious Diseases and Therapy | Issue 2/2020

Login to get access

Abstract

Introduction

Blood cultures (BCs) frequently become contaminated during the pre-analytic phase of collection leading to downstream ramifications. We present a summary of performance improvement (PI) interventions provided by four hospital systems and common factors that contributed to decreased blood culture contamination (BCC) rates.

Methods

Each hospital independently formed a multidisciplinary team and action plan for implementation of their intervention, focusing on the use of educational and training tools. Their goal was to significantly decrease their BCC rates. Pre- and post-intervention data were compared during the sustainment period to determine their success.

Results

All hospitals met their goals of post-intervention BCC rates and with most achieving and sustaining BCC rates ≤ 1.0–2.0%.

Conclusion

Our report highlights how four hospitals independently achieved their objective to decrease their BCC rate with the support of a multidisciplinary team. We propose a benchmark for BCC rates of 1.5 to < 2.0% as achievable and sustainable.
Literature
8.
go back to reference Bekeris L, Tworek JA, Walsh MK, Valenstein PN. Trends in blood culture contamination. A college of American Pathologists Q-Tracks Study of 356 Institutions. Arch Pathol Lab Med. 2005;129:1222–5.CrossRefPubMed Bekeris L, Tworek JA, Walsh MK, Valenstein PN. Trends in blood culture contamination. A college of American Pathologists Q-Tracks Study of 356 Institutions. Arch Pathol Lab Med. 2005;129:1222–5.CrossRefPubMed
10.
go back to reference Garcia RA, Spitzer ED, Beaudry J, Beck C, Diblasi R, Gilleeny-Biabac M, et al. Multidisciplinary team review of best practices for collection and handling of blood cultures to determine effective interventions for increasing the yield of true-positive bacteremias, reducing contamination, and eliminating false-positive central line-associated bloodstream infections. Am J Infect Control. 2015;43:1222–37. https://doi.org/10.1016/j.ajic.2015.06.030.CrossRefPubMed Garcia RA, Spitzer ED, Beaudry J, Beck C, Diblasi R, Gilleeny-Biabac M, et al. Multidisciplinary team review of best practices for collection and handling of blood cultures to determine effective interventions for increasing the yield of true-positive bacteremias, reducing contamination, and eliminating false-positive central line-associated bloodstream infections. Am J Infect Control. 2015;43:1222–37. https://​doi.​org/​10.​1016/​j.​ajic.​2015.​06.​030.CrossRefPubMed
14.
go back to reference Proehl JA, Leviner S, Bradford JY, Storer A, Barnason S, Brim C, et al. Clinical practice guideline: prevention of blood culture contamination (full version). Emerg Nurse Assoc (ENA) 2012:1–12. Proehl JA, Leviner S, Bradford JY, Storer A, Barnason S, Brim C, et al. Clinical practice guideline: prevention of blood culture contamination (full version). Emerg Nurse Assoc (ENA) 2012:1–12.
18.
go back to reference Chen AI, Nachamkin I. Assessing patterns of blood culture utilization at a University Hospital. Abstracts of the ASM Microbe 2017, June 1–5, 2017. New Orleans, LA, Poster No. 246. Chen AI, Nachamkin I. Assessing patterns of blood culture utilization at a University Hospital. Abstracts of the ASM Microbe 2017, June 1–5, 2017. New Orleans, LA, Poster No. 246.
20.
go back to reference Miller R, Cancelleri J, McCurdy L, Sautter RL. A multidisciplinary approach to lowering blood culture contamination rates. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 2011, September 17, 2011. Chicago, IL, Poster No. D-097. Miller R, Cancelleri J, McCurdy L, Sautter RL. A multidisciplinary approach to lowering blood culture contamination rates. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 2011, September 17, 2011. Chicago, IL, Poster No. D-097.
26.
go back to reference Wilson, ML, Mitchell M, Morris AJ, Murray PR, Reimer LG, Reller LB. Principles and procedures for blood cultures: approved guideline. CLSI document M47-A. Wayne PA 2007. Wilson, ML, Mitchell M, Morris AJ, Murray PR, Reimer LG, Reller LB. Principles and procedures for blood cultures: approved guideline. CLSI document M47-A. Wayne PA 2007.
32.
go back to reference Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1–45. https://doi.org/10.1086/599376.CrossRefPubMed Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O’Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1–45. https://​doi.​org/​10.​1086/​599376.CrossRefPubMed
Metadata
Title
Reducing Blood Culture Contamination Rates: Experiences of Four Hospital Systems
Authors
Diane C. Halstead
Robert L. Sautter
James W. Snyder
Arthur E. Crist
Irving Nachamkin
Publication date
01-06-2020
Publisher
Springer Healthcare
Published in
Infectious Diseases and Therapy / Issue 2/2020
Print ISSN: 2193-8229
Electronic ISSN: 2193-6382
DOI
https://doi.org/10.1007/s40121-020-00299-1

Other articles of this Issue 2/2020

Infectious Diseases and Therapy 2/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine